GlycoMimetics Inc reports results for the quarter ended in June - Earnings Summary

Crescent Biopharma

05/08/2021 20:44

* GlycoMimetics Inc  GLYC.OQ  reported a quarterly adjusted loss
of 28 cents​​ per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 31 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* GlycoMimetics Inc's reported EPS for the quarter was a loss
of 28 cents​.
* The mean earnings estimate of analysts had fallen by
about 0.5% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* GlycoMimetics Inc shares had fallen by 15.1% this quarter and
lost 47.6% so far this year.
* The company reported a quarterly loss of $14.4 million.
* Wall Street's median 12-month price target for GlycoMimetics
Inc is $14.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 5 at 07:44 p.m.  ​All
figures in US dollars unless otherwise stated